nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—SLCO1A2—Chlorambucil—hematologic cancer	0.0995	0.141	CbGbCtD
Tolbutamide—CYP2C18—Ifosfamide—hematologic cancer	0.094	0.133	CbGbCtD
Tolbutamide—SLCO1A2—Prednisolone—hematologic cancer	0.0376	0.0533	CbGbCtD
Tolbutamide—SLCO1A2—Prednisone—hematologic cancer	0.0355	0.0503	CbGbCtD
Tolbutamide—CYP2C9—Bexarotene—hematologic cancer	0.0334	0.0473	CbGbCtD
Tolbutamide—CYP2C8—Bortezomib—hematologic cancer	0.0294	0.0416	CbGbCtD
Tolbutamide—CYP2C9—Idarubicin—hematologic cancer	0.0277	0.0392	CbGbCtD
Tolbutamide—CYP2C19—Bortezomib—hematologic cancer	0.0246	0.0349	CbGbCtD
Tolbutamide—CYP2C8—Ifosfamide—hematologic cancer	0.0225	0.0319	CbGbCtD
Tolbutamide—SLCO1A2—Dexamethasone—hematologic cancer	0.0222	0.0314	CbGbCtD
Tolbutamide—CYP2C19—Thalidomide—hematologic cancer	0.0215	0.0304	CbGbCtD
Tolbutamide—CYP2C9—Bortezomib—hematologic cancer	0.0205	0.029	CbGbCtD
Tolbutamide—CYP2C19—Teniposide—hematologic cancer	0.0205	0.029	CbGbCtD
Tolbutamide—CYP2C8—Nilotinib—hematologic cancer	0.0196	0.0277	CbGbCtD
Tolbutamide—CYP2C19—Ifosfamide—hematologic cancer	0.0189	0.0268	CbGbCtD
Tolbutamide—CYP2C19—Imatinib—hematologic cancer	0.0181	0.0256	CbGbCtD
Tolbutamide—CYP2C9—Thalidomide—hematologic cancer	0.0178	0.0253	CbGbCtD
Tolbutamide—SLCO1A2—Methotrexate—hematologic cancer	0.0178	0.0252	CbGbCtD
Tolbutamide—CYP2C9—Teniposide—hematologic cancer	0.017	0.0241	CbGbCtD
Tolbutamide—CYP2C9—Ifosfamide—hematologic cancer	0.0157	0.0223	CbGbCtD
Tolbutamide—CYP2C9—Imatinib—hematologic cancer	0.015	0.0213	CbGbCtD
Tolbutamide—CYP2C9—Nilotinib—hematologic cancer	0.0136	0.0193	CbGbCtD
Tolbutamide—CYP2C19—Prednisone—hematologic cancer	0.0119	0.0168	CbGbCtD
Tolbutamide—SLC22A6—Methotrexate—hematologic cancer	0.0108	0.0153	CbGbCtD
Tolbutamide—CYP2C8—Etoposide—hematologic cancer	0.0108	0.0152	CbGbCtD
Tolbutamide—CYP2C8—Dexamethasone—hematologic cancer	0.00885	0.0125	CbGbCtD
Tolbutamide—CYP2C9—Cisplatin—hematologic cancer	0.00764	0.0108	CbGbCtD
Tolbutamide—CYP2C19—Dexamethasone—hematologic cancer	0.00743	0.0105	CbGbCtD
Tolbutamide—CYP2C9—Dexamethasone—hematologic cancer	0.00617	0.00874	CbGbCtD
Tolbutamide—Gliclazide—VEGFA—hematologic cancer	0.00118	0.314	CrCbGaD
Tolbutamide—Probenecid—ABCC3—hematologic cancer	0.00096	0.256	CrCbGaD
Tolbutamide—Probenecid—SLC22A1—hematologic cancer	0.000667	0.178	CrCbGaD
Tolbutamide—KCNJ11—hematopoietic system—hematologic cancer	0.000506	0.112	CbGeAlD
Tolbutamide—SLCO2B1—hematopoietic system—hematologic cancer	0.000365	0.0807	CbGeAlD
Tolbutamide—SLCO1A2—hematopoietic system—hematologic cancer	0.000336	0.0743	CbGeAlD
Tolbutamide—Gliclazide—ALB—hematologic cancer	0.000316	0.0843	CrCbGaD
Tolbutamide—Urticaria—Imatinib—hematologic cancer	0.000298	0.00127	CcSEcCtD
Tolbutamide—Leukopenia—Thalidomide—hematologic cancer	0.000297	0.00126	CcSEcCtD
Tolbutamide—Aplastic anaemia—Epirubicin—hematologic cancer	0.000297	0.00126	CcSEcCtD
Tolbutamide—Erythema—Mitoxantrone—hematologic cancer	0.000297	0.00126	CcSEcCtD
Tolbutamide—Dyspepsia—Melphalan—hematologic cancer	0.000296	0.00126	CcSEcCtD
Tolbutamide—Agranulocytosis—Etoposide—hematologic cancer	0.000295	0.00125	CcSEcCtD
Tolbutamide—Pruritus—Procarbazine—hematologic cancer	0.000294	0.00125	CcSEcCtD
Tolbutamide—Nausea—Daunorubicin—hematologic cancer	0.000294	0.00125	CcSEcCtD
Tolbutamide—Nausea—Clofarabine—hematologic cancer	0.000294	0.00125	CcSEcCtD
Tolbutamide—Thrombocytopenia—Bortezomib—hematologic cancer	0.000294	0.00125	CcSEcCtD
Tolbutamide—Nausea—Anagrelide—hematologic cancer	0.000293	0.00125	CcSEcCtD
Tolbutamide—Nausea—Pentostatin—hematologic cancer	0.000293	0.00125	CcSEcCtD
Tolbutamide—Urticaria—Cladribine—hematologic cancer	0.000293	0.00124	CcSEcCtD
Tolbutamide—Thrombocytopenia—Bleomycin—hematologic cancer	0.000292	0.00124	CcSEcCtD
Tolbutamide—Rash—Teniposide—hematologic cancer	0.000292	0.00124	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Melphalan—hematologic cancer	0.00029	0.00123	CcSEcCtD
Tolbutamide—Headache—Teniposide—hematologic cancer	0.00029	0.00123	CcSEcCtD
Tolbutamide—Erythema—Gemcitabine—hematologic cancer	0.000289	0.00123	CcSEcCtD
Tolbutamide—Pruritus—Dasatinib—hematologic cancer	0.000289	0.00123	CcSEcCtD
Tolbutamide—Pruritus—Bexarotene—hematologic cancer	0.000289	0.00123	CcSEcCtD
Tolbutamide—Pruritus—Fludarabine—hematologic cancer	0.000288	0.00122	CcSEcCtD
Tolbutamide—Dyspepsia—Lenalidomide—hematologic cancer	0.000288	0.00122	CcSEcCtD
Tolbutamide—Thrombocytopenia—Vinorelbine—hematologic cancer	0.000287	0.00122	CcSEcCtD
Tolbutamide—Leukopenia—Carmustine—hematologic cancer	0.000286	0.00121	CcSEcCtD
Tolbutamide—Dyspepsia—Hydroxyurea—hematologic cancer	0.000284	0.00121	CcSEcCtD
Tolbutamide—Nausea—Idarubicin—hematologic cancer	0.000283	0.0012	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Lenalidomide—hematologic cancer	0.000282	0.0012	CcSEcCtD
Tolbutamide—Leukopenia—Ifosfamide—hematologic cancer	0.00028	0.00119	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Hydroxyurea—hematologic cancer	0.000278	0.00118	CcSEcCtD
Tolbutamide—Nausea—Teniposide—hematologic cancer	0.000275	0.00117	CcSEcCtD
Tolbutamide—Aplastic anaemia—Doxorubicin—hematologic cancer	0.000275	0.00117	CcSEcCtD
Tolbutamide—Thrombocytopenia—Thiotepa—hematologic cancer	0.000274	0.00117	CcSEcCtD
Tolbutamide—Pruritus—Chlorambucil—hematologic cancer	0.000273	0.00116	CcSEcCtD
Tolbutamide—Leukopenia—Vincristine—hematologic cancer	0.000273	0.00116	CcSEcCtD
Tolbutamide—Rash—Busulfan—hematologic cancer	0.000271	0.00115	CcSEcCtD
Tolbutamide—Erythema—Cisplatin—hematologic cancer	0.000269	0.00115	CcSEcCtD
Tolbutamide—CYP2C19—hematopoietic system—hematologic cancer	0.000269	0.0595	CbGeAlD
Tolbutamide—Headache—Busulfan—hematologic cancer	0.000269	0.00114	CcSEcCtD
Tolbutamide—Urticaria—Melphalan—hematologic cancer	0.000267	0.00114	CcSEcCtD
Tolbutamide—Pruritus—Nilotinib—hematologic cancer	0.000267	0.00113	CcSEcCtD
Tolbutamide—Leukopenia—Mitoxantrone—hematologic cancer	0.000266	0.00113	CcSEcCtD
Tolbutamide—Leukopenia—Irinotecan—hematologic cancer	0.000266	0.00113	CcSEcCtD
Tolbutamide—Thrombocytopenia—Thalidomide—hematologic cancer	0.000265	0.00113	CcSEcCtD
Tolbutamide—Pruritus—Imatinib—hematologic cancer	0.000265	0.00113	CcSEcCtD
Tolbutamide—Dyspepsia—Bortezomib—hematologic cancer	0.000265	0.00113	CcSEcCtD
Tolbutamide—Rash—Procarbazine—hematologic cancer	0.000262	0.00112	CcSEcCtD
Tolbutamide—Headache—Procarbazine—hematologic cancer	0.000261	0.00111	CcSEcCtD
Tolbutamide—Pruritus—Cladribine—hematologic cancer	0.000261	0.00111	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Bortezomib—hematologic cancer	0.00026	0.0011	CcSEcCtD
Tolbutamide—Urticaria—Lenalidomide—hematologic cancer	0.00026	0.0011	CcSEcCtD
Tolbutamide—Leukopenia—Gemcitabine—hematologic cancer	0.000259	0.0011	CcSEcCtD
Tolbutamide—Rash—Dasatinib—hematologic cancer	0.000257	0.00109	CcSEcCtD
Tolbutamide—Rash—Bexarotene—hematologic cancer	0.000257	0.00109	CcSEcCtD
Tolbutamide—Rash—Fludarabine—hematologic cancer	0.000257	0.00109	CcSEcCtD
Tolbutamide—Headache—Bexarotene—hematologic cancer	0.000256	0.00109	CcSEcCtD
Tolbutamide—Headache—Dasatinib—hematologic cancer	0.000256	0.00109	CcSEcCtD
Tolbutamide—ABCC8—testis—hematologic cancer	0.000256	0.0565	CbGeAlD
Tolbutamide—Abdominal distension—Prednisone—hematologic cancer	0.000256	0.00109	CcSEcCtD
Tolbutamide—Thrombocytopenia—Carmustine—hematologic cancer	0.000255	0.00108	CcSEcCtD
Tolbutamide—Headache—Fludarabine—hematologic cancer	0.000255	0.00108	CcSEcCtD
Tolbutamide—Nausea—Busulfan—hematologic cancer	0.000255	0.00108	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Vinorelbine—hematologic cancer	0.000253	0.00108	CcSEcCtD
Tolbutamide—Thrombocytopenia—Alitretinoin—hematologic cancer	0.000253	0.00107	CcSEcCtD
Tolbutamide—Thrombocytopenia—Ifosfamide—hematologic cancer	0.00025	0.00106	CcSEcCtD
Tolbutamide—Nausea—Procarbazine—hematologic cancer	0.000247	0.00105	CcSEcCtD
Tolbutamide—Dyspepsia—Thiotepa—hematologic cancer	0.000247	0.00105	CcSEcCtD
Tolbutamide—Thrombocytopenia—Vincristine—hematologic cancer	0.000243	0.00104	CcSEcCtD
Tolbutamide—Erythema—Prednisolone—hematologic cancer	0.000243	0.00103	CcSEcCtD
Tolbutamide—Nausea—Bexarotene—hematologic cancer	0.000242	0.00103	CcSEcCtD
Tolbutamide—Nausea—Dasatinib—hematologic cancer	0.000242	0.00103	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Thiotepa—hematologic cancer	0.000242	0.00103	CcSEcCtD
Tolbutamide—Nausea—Fludarabine—hematologic cancer	0.000242	0.00103	CcSEcCtD
Tolbutamide—Leukopenia—Cisplatin—hematologic cancer	0.000241	0.00103	CcSEcCtD
Tolbutamide—Urticaria—Bortezomib—hematologic cancer	0.000239	0.00102	CcSEcCtD
Tolbutamide—Dyspepsia—Thalidomide—hematologic cancer	0.000239	0.00101	CcSEcCtD
Tolbutamide—Pruritus—Melphalan—hematologic cancer	0.000238	0.00101	CcSEcCtD
Tolbutamide—Rash—Nilotinib—hematologic cancer	0.000238	0.00101	CcSEcCtD
Tolbutamide—Thrombocytopenia—Irinotecan—hematologic cancer	0.000237	0.00101	CcSEcCtD
Tolbutamide—Thrombocytopenia—Mitoxantrone—hematologic cancer	0.000237	0.00101	CcSEcCtD
Tolbutamide—Urticaria—Bleomycin—hematologic cancer	0.000237	0.00101	CcSEcCtD
Tolbutamide—Rash—Imatinib—hematologic cancer	0.000236	0.00101	CcSEcCtD
Tolbutamide—Headache—Nilotinib—hematologic cancer	0.000236	0.001	CcSEcCtD
Tolbutamide—Hypoglycaemia—Epirubicin—hematologic cancer	0.000235	0.001	CcSEcCtD
Tolbutamide—Headache—Imatinib—hematologic cancer	0.000235	0.000999	CcSEcCtD
Tolbutamide—Chlorpropamide—ABCB1—hematologic cancer	0.000235	0.0626	CrCbGaD
Tolbutamide—CYP2C8—hematopoietic system—hematologic cancer	0.000235	0.0519	CbGeAlD
Tolbutamide—Gastrointestinal disorder—Thalidomide—hematologic cancer	0.000234	0.000995	CcSEcCtD
Tolbutamide—Urticaria—Vinorelbine—hematologic cancer	0.000233	0.000992	CcSEcCtD
Tolbutamide—Rash—Cladribine—hematologic cancer	0.000232	0.000988	CcSEcCtD
Tolbutamide—Pruritus—Lenalidomide—hematologic cancer	0.000231	0.000983	CcSEcCtD
Tolbutamide—Thrombocytopenia—Gemcitabine—hematologic cancer	0.000231	0.000982	CcSEcCtD
Tolbutamide—Headache—Cladribine—hematologic cancer	0.000231	0.000981	CcSEcCtD
Tolbutamide—Hyponatraemia—Epirubicin—hematologic cancer	0.000231	0.000981	CcSEcCtD
Tolbutamide—Nausea—Chlorambucil—hematologic cancer	0.000229	0.000974	CcSEcCtD
Tolbutamide—Dyspepsia—Alitretinoin—hematologic cancer	0.000227	0.000966	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Carmustine—hematologic cancer	0.000225	0.000956	CcSEcCtD
Tolbutamide—Nausea—Nilotinib—hematologic cancer	0.000224	0.000952	CcSEcCtD
Tolbutamide—Erythema—Triamcinolone—hematologic cancer	0.000224	0.000952	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Alitretinoin—hematologic cancer	0.000223	0.000947	CcSEcCtD
Tolbutamide—Urticaria—Thiotepa—hematologic cancer	0.000223	0.000947	CcSEcCtD
Tolbutamide—Nausea—Imatinib—hematologic cancer	0.000223	0.000947	CcSEcCtD
Tolbutamide—Headache—Vinblastine—hematologic cancer	0.000221	0.000941	CcSEcCtD
Tolbutamide—Leukopenia—Etoposide—hematologic cancer	0.000221	0.000939	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Ifosfamide—hematologic cancer	0.00022	0.000936	CcSEcCtD
Tolbutamide—Nausea—Cladribine—hematologic cancer	0.000219	0.00093	CcSEcCtD
Tolbutamide—Hypoglycaemia—Doxorubicin—hematologic cancer	0.000218	0.000926	CcSEcCtD
Tolbutamide—Urticaria—Thalidomide—hematologic cancer	0.000215	0.000916	CcSEcCtD
Tolbutamide—Thrombocytopenia—Cisplatin—hematologic cancer	0.000215	0.000915	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Vincristine—hematologic cancer	0.000215	0.000913	CcSEcCtD
Tolbutamide—Hyponatraemia—Doxorubicin—hematologic cancer	0.000213	0.000907	CcSEcCtD
Tolbutamide—Dyspepsia—Mitoxantrone—hematologic cancer	0.000213	0.000906	CcSEcCtD
Tolbutamide—Dyspepsia—Irinotecan—hematologic cancer	0.000213	0.000906	CcSEcCtD
Tolbutamide—Pruritus—Bortezomib—hematologic cancer	0.000213	0.000905	CcSEcCtD
Tolbutamide—SLCO2B1—lung—hematologic cancer	0.000212	0.0469	CbGeAlD
Tolbutamide—Rash—Melphalan—hematologic cancer	0.000212	0.000901	CcSEcCtD
Tolbutamide—Pruritus—Bleomycin—hematologic cancer	0.000211	0.000898	CcSEcCtD
Tolbutamide—Nausea—Vinblastine—hematologic cancer	0.00021	0.000892	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Irinotecan—hematologic cancer	0.000209	0.000889	CcSEcCtD
Tolbutamide—CYP2C9—hematopoietic system—hematologic cancer	0.000208	0.0461	CbGeAlD
Tolbutamide—Pruritus—Vinorelbine—hematologic cancer	0.000208	0.000883	CcSEcCtD
Tolbutamide—Rash—Lenalidomide—hematologic cancer	0.000206	0.000876	CcSEcCtD
Tolbutamide—Urticaria—Alitretinoin—hematologic cancer	0.000205	0.000872	CcSEcCtD
Tolbutamide—Headache—Lenalidomide—hematologic cancer	0.000205	0.00087	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Gemcitabine—hematologic cancer	0.000204	0.000866	CcSEcCtD
Tolbutamide—Probenecid—ALB—hematologic cancer	0.000203	0.0542	CrCbGaD
Tolbutamide—Rash—Hydroxyurea—hematologic cancer	0.000203	0.000864	CcSEcCtD
Tolbutamide—Erythema—Dexamethasone—hematologic cancer	0.000203	0.000864	CcSEcCtD
Tolbutamide—Erythema—Betamethasone—hematologic cancer	0.000203	0.000864	CcSEcCtD
Tolbutamide—Urticaria—Ifosfamide—hematologic cancer	0.000203	0.000861	CcSEcCtD
Tolbutamide—Headache—Hydroxyurea—hematologic cancer	0.000202	0.000858	CcSEcCtD
Tolbutamide—Pancytopenia—Methotrexate—hematologic cancer	0.000201	0.000857	CcSEcCtD
Tolbutamide—KCNJ11—lymph node—hematologic cancer	0.000201	0.0445	CbGeAlD
Tolbutamide—SLCO2B1—testis—hematologic cancer	0.0002	0.0442	CbGeAlD
Tolbutamide—Abdominal distension—Epirubicin—hematologic cancer	0.0002	0.00085	CcSEcCtD
Tolbutamide—Nausea—Melphalan—hematologic cancer	0.0002	0.000849	CcSEcCtD
Tolbutamide—Pruritus—Thiotepa—hematologic cancer	0.000198	0.000843	CcSEcCtD
Tolbutamide—Thrombocytopenia—Etoposide—hematologic cancer	0.000197	0.000838	CcSEcCtD
Tolbutamide—SLCO1A2—lung—hematologic cancer	0.000195	0.0431	CbGeAlD
Tolbutamide—Nausea—Lenalidomide—hematologic cancer	0.000194	0.000825	CcSEcCtD
Tolbutamide—Probenecid—ABCB1—hematologic cancer	0.000194	0.0517	CrCbGaD
Tolbutamide—Photosensitivity reaction—Methotrexate—hematologic cancer	0.000194	0.000823	CcSEcCtD
Tolbutamide—Urticaria—Mitoxantrone—hematologic cancer	0.000192	0.000818	CcSEcCtD
Tolbutamide—Pruritus—Thalidomide—hematologic cancer	0.000192	0.000816	CcSEcCtD
Tolbutamide—Nausea—Hydroxyurea—hematologic cancer	0.000191	0.000814	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Cisplatin—hematologic cancer	0.00019	0.000807	CcSEcCtD
Tolbutamide—Rash—Bortezomib—hematologic cancer	0.00019	0.000806	CcSEcCtD
Tolbutamide—Pancytopenia—Epirubicin—hematologic cancer	0.000189	0.000802	CcSEcCtD
Tolbutamide—Headache—Bortezomib—hematologic cancer	0.000188	0.000801	CcSEcCtD
Tolbutamide—Rash—Bleomycin—hematologic cancer	0.000188	0.0008	CcSEcCtD
Tolbutamide—Rash—Vinorelbine—hematologic cancer	0.000185	0.000787	CcSEcCtD
Tolbutamide—Abdominal distension—Doxorubicin—hematologic cancer	0.000185	0.000786	CcSEcCtD
Tolbutamide—SLC15A2—blood—hematologic cancer	0.000185	0.0408	CbGeAlD
Tolbutamide—SLCO1A2—testis—hematologic cancer	0.000184	0.0407	CbGeAlD
Tolbutamide—Headache—Vinorelbine—hematologic cancer	0.000184	0.000782	CcSEcCtD
Tolbutamide—Pruritus—Alitretinoin—hematologic cancer	0.000183	0.000776	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Epirubicin—hematologic cancer	0.000181	0.000771	CcSEcCtD
Tolbutamide—Pruritus—Ifosfamide—hematologic cancer	0.00018	0.000767	CcSEcCtD
Tolbutamide—Nausea—Bortezomib—hematologic cancer	0.000179	0.000759	CcSEcCtD
Tolbutamide—CYP2C19—blood—hematologic cancer	0.000178	0.0394	CbGeAlD
Tolbutamide—Nausea—Bleomycin—hematologic cancer	0.000177	0.000754	CcSEcCtD
Tolbutamide—Erythema—Prednisone—hematologic cancer	0.000177	0.000752	CcSEcCtD
Tolbutamide—Rash—Thiotepa—hematologic cancer	0.000177	0.000752	CcSEcCtD
Tolbutamide—Agranulocytosis—Methotrexate—hematologic cancer	0.000176	0.000751	CcSEcCtD
Tolbutamide—Headache—Thiotepa—hematologic cancer	0.000176	0.000747	CcSEcCtD
Tolbutamide—Pancytopenia—Doxorubicin—hematologic cancer	0.000174	0.000742	CcSEcCtD
Tolbutamide—Nausea—Vinorelbine—hematologic cancer	0.000174	0.000741	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000174	0.000739	CcSEcCtD
Tolbutamide—Rash—Thalidomide—hematologic cancer	0.000171	0.000727	CcSEcCtD
Tolbutamide—Headache—Thalidomide—hematologic cancer	0.00017	0.000722	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Doxorubicin—hematologic cancer	0.000168	0.000713	CcSEcCtD
Tolbutamide—Pruritus—Gemcitabine—hematologic cancer	0.000167	0.00071	CcSEcCtD
Tolbutamide—Nausea—Thiotepa—hematologic cancer	0.000167	0.000708	CcSEcCtD
Tolbutamide—Agranulocytosis—Epirubicin—hematologic cancer	0.000165	0.000702	CcSEcCtD
Tolbutamide—Rash—Carmustine—hematologic cancer	0.000164	0.000698	CcSEcCtD
Tolbutamide—Headache—Carmustine—hematologic cancer	0.000163	0.000694	CcSEcCtD
Tolbutamide—Rash—Alitretinoin—hematologic cancer	0.000163	0.000692	CcSEcCtD
Tolbutamide—Thrombocytopenia—Betamethasone—hematologic cancer	0.000162	0.00069	CcSEcCtD
Tolbutamide—Thrombocytopenia—Dexamethasone—hematologic cancer	0.000162	0.00069	CcSEcCtD
Tolbutamide—SLC15A2—lung—hematologic cancer	0.000162	0.0358	CbGeAlD
Tolbutamide—Headache—Alitretinoin—hematologic cancer	0.000162	0.000687	CcSEcCtD
Tolbutamide—Nausea—Thalidomide—hematologic cancer	0.000161	0.000685	CcSEcCtD
Tolbutamide—Dyspepsia—Triamcinolone—hematologic cancer	0.000161	0.000684	CcSEcCtD
Tolbutamide—Rash—Ifosfamide—hematologic cancer	0.000161	0.000684	CcSEcCtD
Tolbutamide—Urticaria—Etoposide—hematologic cancer	0.00016	0.00068	CcSEcCtD
Tolbutamide—Urticaria—Prednisolone—hematologic cancer	0.000158	0.000671	CcSEcCtD
Tolbutamide—Rash—Vincristine—hematologic cancer	0.000157	0.000667	CcSEcCtD
Tolbutamide—Headache—Vincristine—hematologic cancer	0.000156	0.000662	CcSEcCtD
Tolbutamide—CYP2C8—blood—hematologic cancer	0.000155	0.0344	CbGeAlD
Tolbutamide—Nausea—Carmustine—hematologic cancer	0.000155	0.000658	CcSEcCtD
Tolbutamide—Nausea—Alitretinoin—hematologic cancer	0.000153	0.000652	CcSEcCtD
Tolbutamide—Agranulocytosis—Doxorubicin—hematologic cancer	0.000153	0.00065	CcSEcCtD
Tolbutamide—SLC15A2—testis—hematologic cancer	0.000153	0.0338	CbGeAlD
Tolbutamide—Rash—Irinotecan—hematologic cancer	0.000153	0.000649	CcSEcCtD
Tolbutamide—Rash—Mitoxantrone—hematologic cancer	0.000153	0.000649	CcSEcCtD
Tolbutamide—Headache—Mitoxantrone—hematologic cancer	0.000152	0.000645	CcSEcCtD
Tolbutamide—Headache—Irinotecan—hematologic cancer	0.000152	0.000645	CcSEcCtD
Tolbutamide—Nausea—Ifosfamide—hematologic cancer	0.000151	0.000644	CcSEcCtD
Tolbutamide—Rash—Gemcitabine—hematologic cancer	0.000149	0.000632	CcSEcCtD
Tolbutamide—Erythema—Methotrexate—hematologic cancer	0.000148	0.000629	CcSEcCtD
Tolbutamide—Headache—Gemcitabine—hematologic cancer	0.000148	0.000628	CcSEcCtD
Tolbutamide—Nausea—Vincristine—hematologic cancer	0.000148	0.000628	CcSEcCtD
Tolbutamide—Dyspepsia—Dexamethasone—hematologic cancer	0.000146	0.00062	CcSEcCtD
Tolbutamide—Dyspepsia—Betamethasone—hematologic cancer	0.000146	0.00062	CcSEcCtD
Tolbutamide—Urticaria—Triamcinolone—hematologic cancer	0.000145	0.000617	CcSEcCtD
Tolbutamide—SLCO2B1—lymph node—hematologic cancer	0.000145	0.0321	CbGeAlD
Tolbutamide—Nausea—Irinotecan—hematologic cancer	0.000144	0.000612	CcSEcCtD
Tolbutamide—Nausea—Mitoxantrone—hematologic cancer	0.000144	0.000612	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000143	0.000608	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000143	0.000608	CcSEcCtD
Tolbutamide—Pruritus—Etoposide—hematologic cancer	0.000142	0.000606	CcSEcCtD
Tolbutamide—Nausea—Gemcitabine—hematologic cancer	0.00014	0.000596	CcSEcCtD
Tolbutamide—Rash—Cisplatin—hematologic cancer	0.000139	0.000589	CcSEcCtD
Tolbutamide—Erythema—Epirubicin—hematologic cancer	0.000138	0.000588	CcSEcCtD
Tolbutamide—CYP2C9—blood—hematologic cancer	0.000138	0.0305	CbGeAlD
Tolbutamide—Leukopenia—Methotrexate—hematologic cancer	0.000132	0.000563	CcSEcCtD
Tolbutamide—Urticaria—Dexamethasone—hematologic cancer	0.000132	0.00056	CcSEcCtD
Tolbutamide—Urticaria—Betamethasone—hematologic cancer	0.000132	0.00056	CcSEcCtD
Tolbutamide—Nausea—Cisplatin—hematologic cancer	0.000131	0.000555	CcSEcCtD
Tolbutamide—Pruritus—Triamcinolone—hematologic cancer	0.000129	0.00055	CcSEcCtD
Tolbutamide—CYP2C8—testis—hematologic cancer	0.000129	0.0284	CbGeAlD
Tolbutamide—Erythema—Doxorubicin—hematologic cancer	0.000128	0.000544	CcSEcCtD
Tolbutamide—Dyspepsia—Prednisone—hematologic cancer	0.000127	0.00054	CcSEcCtD
Tolbutamide—Rash—Etoposide—hematologic cancer	0.000127	0.00054	CcSEcCtD
Tolbutamide—Headache—Etoposide—hematologic cancer	0.000126	0.000536	CcSEcCtD
Tolbutamide—Rash—Prednisolone—hematologic cancer	0.000125	0.000533	CcSEcCtD
Tolbutamide—Headache—Prednisolone—hematologic cancer	0.000124	0.000529	CcSEcCtD
Tolbutamide—Leukopenia—Epirubicin—hematologic cancer	0.000124	0.000526	CcSEcCtD
Tolbutamide—Nausea—Etoposide—hematologic cancer	0.00012	0.000509	CcSEcCtD
Tolbutamide—Thrombocytopenia—Methotrexate—hematologic cancer	0.000118	0.000502	CcSEcCtD
Tolbutamide—Nausea—Prednisolone—hematologic cancer	0.000118	0.000502	CcSEcCtD
Tolbutamide—Pruritus—Dexamethasone—hematologic cancer	0.000117	0.000499	CcSEcCtD
Tolbutamide—Pruritus—Betamethasone—hematologic cancer	0.000117	0.000499	CcSEcCtD
Tolbutamide—Rash—Triamcinolone—hematologic cancer	0.000115	0.00049	CcSEcCtD
Tolbutamide—Urticaria—Prednisone—hematologic cancer	0.000115	0.000488	CcSEcCtD
Tolbutamide—Leukopenia—Doxorubicin—hematologic cancer	0.000115	0.000487	CcSEcCtD
Tolbutamide—Headache—Triamcinolone—hematologic cancer	0.000114	0.000487	CcSEcCtD
Tolbutamide—SLC15A2—lymph node—hematologic cancer	0.000111	0.0245	CbGeAlD
Tolbutamide—Thrombocytopenia—Epirubicin—hematologic cancer	0.000111	0.00047	CcSEcCtD
Tolbutamide—Nausea—Triamcinolone—hematologic cancer	0.000108	0.000461	CcSEcCtD
Tolbutamide—Dyspepsia—Methotrexate—hematologic cancer	0.000106	0.000452	CcSEcCtD
Tolbutamide—Rash—Dexamethasone—hematologic cancer	0.000104	0.000444	CcSEcCtD
Tolbutamide—Rash—Betamethasone—hematologic cancer	0.000104	0.000444	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Methotrexate—hematologic cancer	0.000104	0.000443	CcSEcCtD
Tolbutamide—Headache—Betamethasone—hematologic cancer	0.000104	0.000442	CcSEcCtD
Tolbutamide—Headache—Dexamethasone—hematologic cancer	0.000104	0.000442	CcSEcCtD
Tolbutamide—Thrombocytopenia—Doxorubicin—hematologic cancer	0.000102	0.000435	CcSEcCtD
Tolbutamide—Pruritus—Prednisone—hematologic cancer	0.000102	0.000434	CcSEcCtD
Tolbutamide—Dyspepsia—Epirubicin—hematologic cancer	9.94e-05	0.000423	CcSEcCtD
Tolbutamide—Nausea—Dexamethasone—hematologic cancer	9.84e-05	0.000419	CcSEcCtD
Tolbutamide—Nausea—Betamethasone—hematologic cancer	9.84e-05	0.000419	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Epirubicin—hematologic cancer	9.75e-05	0.000414	CcSEcCtD
Tolbutamide—Urticaria—Methotrexate—hematologic cancer	9.58e-05	0.000407	CcSEcCtD
Tolbutamide—Dyspepsia—Doxorubicin—hematologic cancer	9.19e-05	0.000391	CcSEcCtD
Tolbutamide—Rash—Prednisone—hematologic cancer	9.1e-05	0.000387	CcSEcCtD
Tolbutamide—Headache—Prednisone—hematologic cancer	9.04e-05	0.000385	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	9.02e-05	0.000383	CcSEcCtD
Tolbutamide—Urticaria—Epirubicin—hematologic cancer	8.97e-05	0.000381	CcSEcCtD
Tolbutamide—Nausea—Prednisone—hematologic cancer	8.57e-05	0.000365	CcSEcCtD
Tolbutamide—Pruritus—Methotrexate—hematologic cancer	8.53e-05	0.000363	CcSEcCtD
Tolbutamide—Urticaria—Doxorubicin—hematologic cancer	8.3e-05	0.000353	CcSEcCtD
Tolbutamide—Pruritus—Epirubicin—hematologic cancer	7.99e-05	0.00034	CcSEcCtD
Tolbutamide—Rash—Methotrexate—hematologic cancer	7.61e-05	0.000323	CcSEcCtD
Tolbutamide—Headache—Methotrexate—hematologic cancer	7.56e-05	0.000321	CcSEcCtD
Tolbutamide—Pruritus—Doxorubicin—hematologic cancer	7.39e-05	0.000314	CcSEcCtD
Tolbutamide—Nausea—Methotrexate—hematologic cancer	7.16e-05	0.000305	CcSEcCtD
Tolbutamide—Rash—Epirubicin—hematologic cancer	7.12e-05	0.000303	CcSEcCtD
Tolbutamide—Headache—Epirubicin—hematologic cancer	7.07e-05	0.000301	CcSEcCtD
Tolbutamide—Nausea—Epirubicin—hematologic cancer	6.7e-05	0.000285	CcSEcCtD
Tolbutamide—Rash—Doxorubicin—hematologic cancer	6.59e-05	0.00028	CcSEcCtD
Tolbutamide—Headache—Doxorubicin—hematologic cancer	6.54e-05	0.000278	CcSEcCtD
Tolbutamide—Nausea—Doxorubicin—hematologic cancer	6.2e-05	0.000264	CcSEcCtD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.55e-05	0.000306	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CDA—hematologic cancer	1.52e-05	0.000301	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—HDC—hematologic cancer	1.52e-05	0.0003	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.51e-05	0.000298	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—NCOR1—hematologic cancer	1.51e-05	0.000298	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—GSTM1—hematologic cancer	1.51e-05	0.000298	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.5e-05	0.000297	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CYCS—hematologic cancer	1.49e-05	0.000295	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—HSP90AA1—hematologic cancer	1.48e-05	0.000294	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.48e-05	0.000293	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PC—hematologic cancer	1.46e-05	0.000289	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—MTAP—hematologic cancer	1.45e-05	0.000286	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.42e-05	0.000281	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.42e-05	0.00028	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GBA—hematologic cancer	1.41e-05	0.000279	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SLC35B2—hematologic cancer	1.41e-05	0.000279	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.41e-05	0.000279	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.41e-05	0.000279	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CDA—hematologic cancer	1.39e-05	0.000274	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—MTHFR—hematologic cancer	1.37e-05	0.000272	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CD44—hematologic cancer	1.34e-05	0.000265	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—NQO1—hematologic cancer	1.34e-05	0.000265	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PC—hematologic cancer	1.33e-05	0.000264	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—MTHFR—hematologic cancer	1.33e-05	0.000263	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—ALB—hematologic cancer	1.33e-05	0.000262	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GSTP1—hematologic cancer	1.32e-05	0.00026	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.31e-05	0.000259	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—MTAP—hematologic cancer	1.29e-05	0.000256	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—FHL2—hematologic cancer	1.29e-05	0.000255	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GBA—hematologic cancer	1.29e-05	0.000255	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLC35B2—hematologic cancer	1.29e-05	0.000255	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CYCS—hematologic cancer	1.27e-05	0.00025	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—AGRN—hematologic cancer	1.27e-05	0.00025	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—HSP90AA1—hematologic cancer	1.26e-05	0.000249	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ABCB1—hematologic cancer	1.25e-05	0.000247	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GSTM1—hematologic cancer	1.21e-05	0.000239	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—NCOR1—hematologic cancer	1.21e-05	0.000239	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—IDH2—hematologic cancer	1.2e-05	0.000237	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—HMMR—hematologic cancer	1.2e-05	0.000237	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—MTAP—hematologic cancer	1.18e-05	0.000233	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PIK3CG—hematologic cancer	1.15e-05	0.000228	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—FHL2—hematologic cancer	1.15e-05	0.000228	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.13e-05	0.000224	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.13e-05	0.000224	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—AGRN—hematologic cancer	1.13e-05	0.000223	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ARNTL—hematologic cancer	1.13e-05	0.000223	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PIK3CG—hematologic cancer	1.12e-05	0.000221	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GSTP1—hematologic cancer	1.12e-05	0.000221	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CA9—hematologic cancer	1.1e-05	0.000217	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ACP5—hematologic cancer	1.1e-05	0.000217	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NCOR2—hematologic cancer	1.08e-05	0.000214	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.08e-05	0.000213	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—IDH2—hematologic cancer	1.07e-05	0.000212	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—HMMR—hematologic cancer	1.07e-05	0.000212	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—MTHFR—hematologic cancer	1.07e-05	0.000212	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CREBBP—hematologic cancer	1.07e-05	0.000212	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ABCB1—hematologic cancer	1.06e-05	0.000209	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—FHL2—hematologic cancer	1.05e-05	0.000208	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CREBBP—hematologic cancer	1.04e-05	0.000205	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—IDH1—hematologic cancer	1.03e-05	0.000204	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—AGRN—hematologic cancer	1.03e-05	0.000204	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—NCOR1—hematologic cancer	1.03e-05	0.000203	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GSTM1—hematologic cancer	1.03e-05	0.000203	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—TXN—hematologic cancer	1.02e-05	0.000202	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSTO1—hematologic cancer	1.02e-05	0.000202	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ABCC3—hematologic cancer	1.02e-05	0.000202	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PIK3CD—hematologic cancer	1.01e-05	0.000201	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.01e-05	0.0002	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ARNTL—hematologic cancer	1.01e-05	0.000199	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—ALB—hematologic cancer	1e-05	0.000198	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SPHK1—hematologic cancer	9.98e-06	0.000197	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PIK3CD—hematologic cancer	9.83e-06	0.000194	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CA9—hematologic cancer	9.79e-06	0.000194	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ACP5—hematologic cancer	9.79e-06	0.000194	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—IDH2—hematologic cancer	9.76e-06	0.000193	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—HMMR—hematologic cancer	9.76e-06	0.000193	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—ALB—hematologic cancer	9.71e-06	0.000192	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NCOR2—hematologic cancer	9.67e-06	0.000191	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—UGT1A1—hematologic cancer	9.59e-06	0.00019	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PIK3R1—hematologic cancer	9.58e-06	0.000189	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CRABP1—hematologic cancer	9.33e-06	0.000184	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SLC22A1—hematologic cancer	9.33e-06	0.000184	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PIK3R1—hematologic cancer	9.29e-06	0.000184	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—IDH1—hematologic cancer	9.21e-06	0.000182	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	9.21e-06	0.000182	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ARNTL—hematologic cancer	9.18e-06	0.000182	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTO1—hematologic cancer	9.1e-06	0.00018	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—TXN—hematologic cancer	9.1e-06	0.00018	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ABCC3—hematologic cancer	9.1e-06	0.00018	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ALOX5—hematologic cancer	9.09e-06	0.00018	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—MTHFR—hematologic cancer	9.06e-06	0.000179	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PIK3CG—hematologic cancer	8.99e-06	0.000178	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ACP5—hematologic cancer	8.93e-06	0.000177	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CA9—hematologic cancer	8.93e-06	0.000177	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SPHK1—hematologic cancer	8.91e-06	0.000176	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PIK3CB—hematologic cancer	8.84e-06	0.000175	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NCOR2—hematologic cancer	8.81e-06	0.000174	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NUP98—hematologic cancer	8.81e-06	0.000174	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PIK3CB—hematologic cancer	8.57e-06	0.000169	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—UGT1A1—hematologic cancer	8.56e-06	0.000169	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NCOA3—hematologic cancer	8.55e-06	0.000169	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ADCY7—hematologic cancer	8.55e-06	0.000169	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NUP214—hematologic cancer	8.49e-06	0.000168	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	8.4e-06	0.000166	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—IDH1—hematologic cancer	8.4e-06	0.000166	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CREBBP—hematologic cancer	8.33e-06	0.000165	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CRABP1—hematologic cancer	8.33e-06	0.000165	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SLC22A1—hematologic cancer	8.33e-06	0.000165	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—MTR—hematologic cancer	8.32e-06	0.000164	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ABCG2—hematologic cancer	8.32e-06	0.000164	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTO1—hematologic cancer	8.3e-06	0.000164	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—TXN—hematologic cancer	8.3e-06	0.000164	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ABCC3—hematologic cancer	8.3e-06	0.000164	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ENO2—hematologic cancer	8.15e-06	0.000161	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SPHK1—hematologic cancer	8.12e-06	0.000161	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ALOX5—hematologic cancer	8.11e-06	0.00016	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7.98e-06	0.000158	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSTT1—hematologic cancer	7.91e-06	0.000156	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PIK3CD—hematologic cancer	7.9e-06	0.000156	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NUP98—hematologic cancer	7.86e-06	0.000155	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—UGT1A1—hematologic cancer	7.81e-06	0.000154	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ALB—hematologic cancer	7.8e-06	0.000154	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.79e-06	0.000154	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SDC1—hematologic cancer	7.73e-06	0.000153	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PTEN—hematologic cancer	7.64e-06	0.000151	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NCOA3—hematologic cancer	7.63e-06	0.000151	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ADCY7—hematologic cancer	7.63e-06	0.000151	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PIK3CG—hematologic cancer	7.61e-06	0.000151	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLC22A1—hematologic cancer	7.59e-06	0.00015	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CRABP1—hematologic cancer	7.59e-06	0.00015	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NUP214—hematologic cancer	7.58e-06	0.00015	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.5e-06	0.000148	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PIK3R1—hematologic cancer	7.46e-06	0.000148	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—MTR—hematologic cancer	7.42e-06	0.000147	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ABCG2—hematologic cancer	7.42e-06	0.000147	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PTEN—hematologic cancer	7.41e-06	0.000146	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ALOX5—hematologic cancer	7.4e-06	0.000146	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.38e-06	0.000146	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.29e-06	0.000144	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—EP300—hematologic cancer	7.28e-06	0.000144	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ENO2—hematologic cancer	7.28e-06	0.000144	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NUP98—hematologic cancer	7.17e-06	0.000142	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—EP300—hematologic cancer	7.06e-06	0.00014	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTT1—hematologic cancer	7.06e-06	0.00014	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CREBBP—hematologic cancer	7.06e-06	0.00014	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.97e-06	0.000138	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ADCY7—hematologic cancer	6.96e-06	0.000138	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NCOA3—hematologic cancer	6.96e-06	0.000138	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.95e-06	0.000137	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NUP214—hematologic cancer	6.91e-06	0.000137	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SDC1—hematologic cancer	6.9e-06	0.000136	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PIK3CB—hematologic cancer	6.89e-06	0.000136	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.84e-06	0.000135	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—MTR—hematologic cancer	6.77e-06	0.000134	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ABCG2—hematologic cancer	6.77e-06	0.000134	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PIK3CD—hematologic cancer	6.69e-06	0.000132	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ENO2—hematologic cancer	6.64e-06	0.000131	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ALB—hematologic cancer	6.61e-06	0.000131	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.59e-06	0.00013	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CD44—hematologic cancer	6.57e-06	0.00013	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NQO1—hematologic cancer	6.57e-06	0.00013	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.51e-06	0.000129	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTT1—hematologic cancer	6.44e-06	0.000127	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.44e-06	0.000127	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.34e-06	0.000125	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PIK3R1—hematologic cancer	6.32e-06	0.000125	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SDC1—hematologic cancer	6.29e-06	0.000124	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.22e-06	0.000123	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYCS—hematologic cancer	6.22e-06	0.000123	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	6.18e-06	0.000122	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.01e-06	0.000119	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PTEN—hematologic cancer	5.95e-06	0.000118	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.93e-06	0.000117	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CD44—hematologic cancer	5.87e-06	0.000116	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NQO1—hematologic cancer	5.87e-06	0.000116	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PIK3CB—hematologic cancer	5.83e-06	0.000115	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.74e-06	0.000114	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—EP300—hematologic cancer	5.67e-06	0.000112	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.67e-06	0.000112	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.56e-06	0.00011	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYCS—hematologic cancer	5.55e-06	0.00011	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	5.52e-06	0.000109	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSTP1—hematologic cancer	5.48e-06	0.000108	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PIK3CA—hematologic cancer	5.39e-06	0.000107	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NQO1—hematologic cancer	5.35e-06	0.000106	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CD44—hematologic cancer	5.35e-06	0.000106	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.3e-06	0.000105	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.24e-06	0.000104	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PIK3CA—hematologic cancer	5.23e-06	0.000103	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ABCB1—hematologic cancer	5.19e-06	0.000103	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYCS—hematologic cancer	5.06e-06	0.0001	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PTEN—hematologic cancer	5.04e-06	9.97e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSTM1—hematologic cancer	5.04e-06	9.96e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NCOR1—hematologic cancer	5.04e-06	9.96e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	5.03e-06	9.95e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.96e-06	9.82e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTP1—hematologic cancer	4.89e-06	9.68e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—EP300—hematologic cancer	4.81e-06	9.51e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.73e-06	9.36e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ABCB1—hematologic cancer	4.63e-06	9.16e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.53e-06	8.95e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NCOR1—hematologic cancer	4.5e-06	8.89e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTM1—hematologic cancer	4.5e-06	8.89e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTP1—hematologic cancer	4.46e-06	8.82e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—MTHFR—hematologic cancer	4.45e-06	8.8e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—AKT1—hematologic cancer	4.4e-06	8.7e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.32e-06	8.54e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—AKT1—hematologic cancer	4.27e-06	8.44e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ABCB1—hematologic cancer	4.22e-06	8.35e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PIK3CA—hematologic cancer	4.2e-06	8.3e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NCOR1—hematologic cancer	4.1e-06	8.11e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTM1—hematologic cancer	4.1e-06	8.11e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—MTHFR—hematologic cancer	3.97e-06	7.86e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.92e-06	7.76e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PIK3CG—hematologic cancer	3.74e-06	7.4e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.62e-06	7.17e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	3.56e-06	7.03e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.5e-06	6.93e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CREBBP—hematologic cancer	3.47e-06	6.86e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—AKT1—hematologic cancer	3.43e-06	6.78e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PIK3CG—hematologic cancer	3.34e-06	6.6e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PIK3CD—hematologic cancer	3.29e-06	6.5e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ALB—hematologic cancer	3.25e-06	6.42e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.19e-06	6.31e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PIK3R1—hematologic cancer	3.11e-06	6.14e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CREBBP—hematologic cancer	3.1e-06	6.12e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PIK3CG—hematologic cancer	3.04e-06	6.02e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.94e-06	5.8e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—AKT1—hematologic cancer	2.9e-06	5.74e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ALB—hematologic cancer	2.9e-06	5.73e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.87e-06	5.67e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.82e-06	5.58e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.77e-06	5.48e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.68e-06	5.29e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ALB—hematologic cancer	2.64e-06	5.22e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.56e-06	5.06e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.53e-06	5e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PTEN—hematologic cancer	2.48e-06	4.9e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—EP300—hematologic cancer	2.36e-06	4.67e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.33e-06	4.61e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PTEN—hematologic cancer	2.21e-06	4.37e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—EP300—hematologic cancer	2.11e-06	4.17e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PTEN—hematologic cancer	2.02e-06	3.99e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—EP300—hematologic cancer	1.92e-06	3.8e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.75e-06	3.46e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.56e-06	3.08e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—AKT1—hematologic cancer	1.43e-06	2.82e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.42e-06	2.81e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—AKT1—hematologic cancer	1.27e-06	2.52e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—AKT1—hematologic cancer	1.16e-06	2.3e-05	CbGpPWpGaD
